Definium Therapeutics, Inc. (NASDAQ: DFTX) — Healthcare · Share Price, Chart & Market Data
About: Definium Therapeutics, Inc., a clinical biopharmaceutical company, develops novel product candidates to treat brain health disorders. The company's lead product candidates DT120, which is in phase 3 for the treatment of generalized anxiety disorder, major depressive disorder, and other brain health disorders; and DT402, a R-enantiomer of 3,4-methylenedioxymethamphetamine, which is in phase 2a clinical trials for the treatment of autism spectrum disorder. The company was formerly known as Mind Medicine (MindMed) Inc. and changed its name to Definium Therapeutics, Inc. in January 2026. Definium Therapeutics, Inc. is headquartered in New York, New York.
Sector: Healthcare
Industry: Biotechnology
Latest price: $22.48 (-3.35%)
DFTXDefinium Therapeutics, Inc.
Loading watchlist status…
Trade DFTX now
Definium Therapeutics, Inc. share price
DFTX price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 12:03 pm GMT+0
DFTX price performance
-5.705%
5D
25.727%
1M
64.809%
YTD
253.459%
1Y
DFTX price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NASDAQ rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 12:03 pm GMT+0
DFTX details
DFTX Market Signals